EP3230316

BAYER HEALTHCARE LLC
Application Number
EP15819965A
Filing Date
Dec 10, 2015
Status
Granted And Under Opposition
Dec 3, 2021
Grant Date
Jan 5, 2022
External Links
Slate, Register

Biblio Summary

The patent EP3230316B1 was granted on Jan 5, 2022 by Bayer Healthcare Llc The patent is currently Granted And Under Opposition.

The table below shows 6 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AMGENOct 5, 2022ADMISSIBLE
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBBOct 5, 2022ADMISSIBLE
BOULT WADE TENNANT LLPOct 5, 2022ADMISSIBLE
MAIWALD GMBHOct 5, 2022ADMISSIBLE
WITHERS & ROGERS LLPOct 4, 2022ADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBOct 4, 2022ADMISSIBLE

The table below shows the patents of Bayer Healthcare Llc that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2772500Site-Directed Modification Of FviiiDec 25, 20191
EP2109394Analyte-Testing DeviceMay 23, 20181